Latest news with #BusinessCorporationsAct
Hamilton Spectator
5 days ago
- Business
- Hamilton Spectator
‘Bona fide' changes to Nunavut law as legislature sitting wraps up
A modernization of Nunavut's pharmacy profession laws was one of five bills approved as the Nunavut legislative assembly's spring sitting came to a close Tuesday. MLAs met in Iqaluit for nine days for the second-last sitting before Nunavummiut head to the polls in the Oct. 27 territorial election. Commissioner Eva Aariak presided over the assent ceremony to sign the bills they passed into law. The Pharmacy Profession Act is what Health Minister John Main has described as an 'modernization' of Nunavut's pharmacy laws. It allows Nunavut pharmacists to administer vaccines and prescribe treatments for minor illnesses. It also establishes a pharmacist registration system, and outlines a complaints and disciplinary process, among other provisions. A supplementary appropriations bill adds $4.2 million in capital budget spending across the territory's departments of justice, family services, and executive and intergovernmental affairs for the fiscal year ending March 31, 2026. The capital budget for the current fiscal year, which totals more than $350 million, was originally tabled in October during the fall sitting. Another bill replaces Latin text with plain language across several territorial laws, such as 'bona fide' with 'good faith' in acts such as the Business Corporations Act and Conflict of Interest Act, and 'ex parte' with 'without notice' in several acts. A lengthy bill that outlines regulations of early learning and child care centres in Nunavut was approved and received assent after it was initially tabled in the winter sitting. Finally, MLAs passed a bill that adjusts which documents are published in the Nunavut Gazette. For example, notices of incorporations will now be published 'on a website maintained by or for the registrar' instead of in the Nunavut Gazette. Some bills didn't pass this assembly. Notably, a proposed amendment to the Vital Statistics Act would have added a non-binary sex option on birth certificates. That would have allowed people who do not identify as male or female to change their birth certificates to that third sex option if they chose to do so. Main said he was hoping the bill would pass this sitting because June is Pride Month. 'Support for gender-diverse individuals, it's very sensitive and it actually is connected to our work on suicide prevention,' Main told reporters last week. 'Individuals who are gender-diverse and are not adequately supported can be at risk of adverse mental health outcomes including suicide attempts or suicide.' However, that bill and two others tabled this sitting await review from the standing committee on legislation. Along with the signing of bills, MLAs offered their parting messages. Notably, Minister David Akeeagok gave early notice that he won't seek re-election this fall as the MLA for Quttiktuk. He wants prospective candidates to start talking with their families about possibly replacing him. Other statements from MLAs Tuesday included celebrations of high school graduates, tributes to individual family and community members, and talk of fishing derbies. Speaker Tony Akoak thanked legislative staff and the chamber's Inuktitut and Innuinaqtun interpreters for their work. 'We have had a very good, productive couple of weeks of meetings in the house,' he said. 'Have a safe journey home.' Error! Sorry, there was an error processing your request. There was a problem with the recaptcha. Please try again. You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy . This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply. Want more of the latest from us? Sign up for more at our newsletter page .
Yahoo
6 days ago
- Business
- Yahoo
Edgemont Enters into Definitive Agreement with Laiva Gold Inc. for Reverse Takeover and Fundamental Change Transaction
Vancouver, British Columbia--(Newsfile Corp. - June 4, 2025) - Edgemont Gold Corp. (CSE: EDGM) (the "Company" or "Edgemont") announces that, further to its news releases dated February 20, 2025, March 21, 2025 and April 15, 2025, it has entered into a merger agreement (the "Definitive Agreement") dated June 4, 2025, with Laiva Gold Inc. ("Laiva"), and 2717194 Alberta Ltd. ("SubCo"), a newly incorporated, wholly-owned subsidiary of the Company. Pursuant to the Definitive Agreement, the Company will acquire all of the issued and outstanding common shares of Laiva (the "Laiva Shares") in exchange for an equivalent number of common shares of the Company (the "Transaction"). The Transaction will constitute a reverse takeover transaction of the Company by Laiva and will be a "Fundamental Change" of the Company under Canadian Securities Exchange ("CSE") Policy 8 - Fundamental Changes and Changes of Business ("Policy 8"). Completion of the Transaction will require approval from the CSE, as well as shareholders of Laiva ("Laiva Shareholders") will also be required to approve the Transaction prior to its closing ("Closing") along with shareholders of the Company ("Edgemont Shareholders") will also need to approve the Transaction as a "Fundamental Change" as a condition to Closing, as discussed further below. Summary of the Transaction The Definitive Agreement structures the Transaction as a three-cornered amalgamation (the "Amalgamation") with Laiva amalgamating with SubCo under the Business Corporations Act (Alberta), with the amalgamated entity becoming a wholly-owned subsidiary of the Company following the Closing (the "Resulting Issuer"). Following Closing, the Resulting Issuer will continue the business of Laiva as a company listed on the CSE as a Mining Issuer under the name "Laiva Gold Corporation" (the "Name Change") or such name as agreed to by the parties. In addition, prior to the Closing, it is expected that the Company and Laiva will complete two private placement offerings (together, the "Concurrent Financings") as follows: (1) a private placement offering of units of Laiva at a price of $0.80 per unit for aggregate gross proceeds of up to $7,500,000 (the "Laiva Private Placement") with each unit consisting of one Laiva Share and one half of one Laiva Share purchase warrant, with each whole warrant exercisable at a price of $1.20 per Laiva Share for a period of 18 months from the date of issuance; and (2) a private placement offering of subscription receipts of the Company at a price per subscription receipt to be determined in the context of the market for aggregate gross proceeds up to $7,500,000 (the "SR Financing"), with each subscription receipt expected to convert into one post-Consolidation Edgemont Share prior to the Closing. Finder's fees may be paid in connection with the Concurrent Financings and will disclosed in due course and as confirmed. In addition, prior to the Closing, the Company will effect a consolidation of its common shares (the "Edgemont Shares") on a 3:1 basis (the "Consolidation"), whereby each holder of Edgemont Shares will receive one post-Consolidation Edgemont Share for each 3 Edgemont Shares held at the time of Consolidation. Certain common shares of the Resulting Issuer to be issued pursuant to the Transaction are expected to be subject to restrictions on resale or escrow under the policies of the CSE, including the securities to be issued to Related Persons (as defined under the CSE policies), which will be subject to the escrow requirements of the CSE. Pursuant to voting support agreements agreed to by the parties, the directors and officers of Laiva, as well as certain key shareholders of Laiva, have agreed to vote in support of the Transaction and related matters. The Definitive Agreement includes a number of conditions precedent to Closing, including but not limited to, receipt of the requisite shareholder approvals from both Edgemont (approving the Transaction as a "Fundamental Change") and Laiva (approving the Amalgamation), completion of the Concurrent Financings, completion of the Consolidation, the Name Change being effected, approvals of all regulatory bodies having jurisdiction in connection with the Transaction, approval of the CSE, including the satisfaction of its listing requirements, the settlement of certain outstanding liabilities of Laiva, the receipt by Laiva of certain environmental permits and the satisfaction of other closing conditions customary to the transactions of this nature. There can be no assurance that the Transaction will be completed as proposed or at all. Following completion of the Transaction, Laiva will become a wholly-owned subsidiary of the Resulting Issuer. The foregoing is a summary of the Definitive Agreement and is qualified in its entirety by the Definitive Agreement, a copy of which will be available under Edgemont's profile on SEDAR+ at The Transaction is not a "related party transaction" (as defined under Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions). The Definitive Agreement contains customary representations, warranties and covenants, including non-solicitation provisions. In addition, the Definitive Agreement provides that a termination fee of $500,000 is payable by Laiva should the Transaction be terminated in certain circumstances. In addition, in the event of termination of the Definitive Agreement, Laiva will repay to Edgemont the amount owing under the bridge loan advance by Edgemont to Laiva (see news release dated February 20, 2025), as well as reimburse Edgemont for certain expenses and fees incurred in connection with the Transaction. Directors and Officers of the Resulting Issuer In conjunction with and upon Closing, the board of directors of the Resulting Issuer is expected to consist of five (5) directors. Certain of the existing directors and officers of the Company will resign at or prior to Closing. Laiva and the Company will make further announcements regarding the expected officers and directors of the Resulting Issuer. Listing Statement In connection with the Transaction and pursuant to the requirements of the CSE, the Company intends on filing a CSE Form 2A listing statement on its issuer profile on SEDAR+ ( and on its CSE issuer profile on the CSE website ( which will contain relevant details regarding the Transaction, Laiva and the Resulting Issuer. Additional Information Additional terms regarding the Transaction were previously disclosed in news releases of the Company dated February 20, 2025, March 21, 2025 and April 15, 2025, which are available under the Company's SEDAR+ profile at Subject to satisfaction or waiver of the conditions precedent referred to in this news release and in the Definitive Agreement, the Company and Laiva anticipate that the Transaction will be completed no later than September 30, 2025. There is no assurance that the Transaction will be completed on the terms proposed herein or at all. Trading in the common shares of the Company has been halted and will remain halted, pending the satisfaction of applicable requirements of CSE Policy 8 and permission to resume trading has been obtained from the CSE. All information contained in this news release with respect to Laiva was supplied by Laiva, and the Company and its directors and officers have relied on Laiva for such information. Completion of the Transaction is subject to a number of conditions, including but not limited to, CSE acceptance. Where applicable, the Transaction cannot close until the required shareholder approval is obtained. There can be no assurance that the Transaction will be completed as proposed or at all. Investors are cautioned that, except as disclosed in the CSE Form 2A listing statement to be prepared in connection with the Transaction, any information released or received with respect to the Transaction may not be accurate or complete and should not be relied upon. Trading in the securities of the Company should be considered highly speculative. The Canadian Securities Exchange has in no way passed upon the merits of the Transaction and has neither approved nor disapproved the contents of this news release. The securities of the Company to be issued in connection with the Transaction have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act") or any U.S. state securities laws and may not be offered or sold in the United States absent registration or an available exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there by any sale of the securities referenced in this press release, in any jurisdiction in which such offer, solicitation or sale would be unlawful. About Laiva Laiva is a Canadian mining company, incorporated under the Alberta Business Corporations Act, and through a subsidiary company owns its flagship operation, the Laiva mine ("Laiva Gold Project") in Finland. The Laiva Gold Project is situated in the North Ostrobothnia region of Finland, along the Gulf of Bothnia coast. It lies approximately 20 kilometres (km) southeast of Raahe, 80 km southwest of Oulu, and 550 km north of Helsinki. The Laiva Gold Project comprises 2 applications for exploration permits and 1 active mining permit covering a total of approximately 22.46 square kilometres (km2). Image 1 To view an enhanced version of this graphic, please visit: The Laiva Gold Project is a historical open-pit mining operation that consists of two open pits. Mineralized material produced from the Laiva Gold Project has historically been processed at the Laiva Gold Mine Process facilities (the "Laiva processing plant"), located within the Laiva Gold Project. The Laiva processing plant was constructed in 2011. Nordic Mines operated the plant from the commission date to the end of March 2014. The mill production rate during this period averaged approximately 210 metric tonnes per hour (mtph) verses the design rate of 250 mtph. The ground mineralized material particle size ranged from P80 110 micrometer (μm) to 130 μm versus a design particle size of P80 75 μm. The mineral processing plant is located approximately 1 km northeast from the South and North open pits on the Property site. The Laiva Gold Project is currently on care and maintenance and is a former gold producing mining operation. The processing plant comprises a single stage crushing circuit, grinding mills, a 3-megawatt (Mw) installed power mill, flash flotation, gravity and regrind circuits, high grade and low grade carbon-in-leach circuits, carbon stripping, and a gold room. Spent mud is sent to either a high grade or low grade dam. The low grade dam is situated approximately 7.5 km from the plant where it is processed through a thickener. A geochemical laboratory is situated within the Property, previously managed by an independent contractor. Geochemical samples were processed and analyzed using a pulverize and leach machine (PAL1000) with 52 steel pots and an Atomic Absorption spectrometer with a capacity of 8,000 samples per week. This laboratory has historically been used to process and analyze grade control samples. Most of the power used to source the Laiva Gold Project operations is from a high-voltage grid in the area. It is located to the east of the Laiva Gold Project and supplies 110 kilovolts (kV) of power. A secondary 20 kV power grid is available from the village of Mattilanperä. About Edgemont Edgemont holds a 100% interest in the Dungate copper/gold porphyry project located just 6 km south of Houston, BC, in a region with a history of successful mining projects including the Equity Silver Mine and Imperial Metals' Huckleberry Mine. The Dungate project is comprised of five mineral tenures covering 1,582.2 hectares that can be explored year-round by all-season roads. For more information, please visit our website at Qualified Person Statement The scientific and technical information contained in this news release have been reviewed and approved by John Williamson, a director of Edgemont, who is a "qualified person" as defined under National Instrument 43-101 - Standards of Disclosure for Mineral Projects. For further information, please contact:Stuart RogersChief Executive OfficerTel: (778) Cautionary Statement Regarding Forward-Looking Information This news release contains forward-looking information or statements within the meaning of applicable securities laws, which may include, without limitation, statements relating to the terms and completion of the Transaction, the receipt of corporate, regulatory and stock exchange approval in respect of the Transaction, the terms and completion of the Concurrent Financings, the technical, financial, and business prospects of the Company and Laiva, their respective assets and other matters. All statements in this news release, other than statements of historical facts, that address events or developments that the Company expects to occur, are forward-looking information or statements. Although the Company believes the expectations expressed in such forward-looking information or statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in the forward-looking information or statements. Such statements and information are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future, the ability to achieve its goals, expected costs and timelines to achieve the Company's goals, that general business and economic conditions will not change in a material adverse manner, and that financing will be available if and when needed and on reasonable terms. Such forward-looking information or statements reflects the Company's views with respect to future events and is subject to risks, uncertainties and assumptions, including the risks and uncertainties included in in documents filed under the Company's profile on SEDAR+ at While such estimates and assumptions are considered reasonable by the management of the Company, they are inherently subject to significant business, economic, competitive, and regulatory uncertainties and risks. Factors that could cause actual results to differ materially from those in forward-looking information or statements include, but are not limited to, the ability of the Company to complete the Offering on the terms described herein, including obtaining the requisite regulatory and stock exchange approvals, continued availability of capital and financing and general economic, market or business conditions, failure to compete effectively with competitors, failure to maintain or obtain all necessary permits, approvals and authorizations, failure to comply with applicable laws, including environmental laws, risks relating to unanticipated operational difficulties. The Company does not undertake to update forward-looking statements or forward-looking information, except as required by law. Neither the Canadian Securities Exchange nor its Market Regulator (as the term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. Not for distribution to United States newswire services or fordissemination in the United States. To view the source version of this press release, please visit Sign in to access your portfolio
Yahoo
30-05-2025
- Business
- Yahoo
Custom Health Enters into Definitive Agreement to Complete Business Combination with Queue Ventures
Vancouver, British Columbia--(Newsfile Corp. - May 30, 2025) - Custom Health, Inc. ("Custom Health"), a technology-enabled healthcare solutions company providing innovative products and services designed to improve the well-being of individuals across North America, has entered into a definitive arrangement agreement dated May 30, 2025 (the "Arrangement Agreement") with Queue Ventures Ltd. ("Queue"). The transaction is expected to provide Custom Health with access to growth capital to support the expansion of its existing business model and operations. In connection with the Transaction, Custom Health and Queue have also entered into an engagement letter with Stifel Nicolaus Canada Inc. ("Stifel") with respect to (the "Offering") (i) a commercially reasonable best efforts private placement of up to 3,000,000 subscription receipts of Custom FundCo (as defined below) ("FundCo Subscription Receipts") at a price per FundCo Subscription Receipt of US$10.00 for aggregate gross proceeds of up to US$30 million, and (ii) a debt financing of up to US$30 million or such other amount and on such terms as may be agreed between Stifel, Queue and Custom Health (the "Debt Financing"). "This milestone is a testament to the power of our model, the trust of our partners, and the dedication of our team," said Shane Bishop, CEO of Custom Health. "We're proud to announce a definitive agreement to take Custom Health public on the TSX - a transformative step that reflects our mission to personalize care at scale. As a public company, we're excited to expand access to our innovative care solutions, improve outcomes for more patients, and deliver value to all our stakeholders." The Transaction Under the Arrangement Agreement with (i) Custom Health, a corporation existing under the laws of Delaware, and Queue, (ii) Custom Merger Sub, Inc. ("Merger Sub"), a corporation existing under the laws of Delaware and a wholly-owned subsidiary of Queue that has been formed for the sole purpose of participating in and facilitating the Arrangement (as defined below), (iii) Queue BC Subco Inc. ("Queue Subco"), a corporation existing under the laws of British Columbia and a wholly-owned subsidiary of Queue that has been formed for the sole purpose of participating in and facilitating the Arrangement, and (iv) Custom Fundco Inc. ("Custom Fundco"), a corporation existing under the laws of British Columbia that has been formed for the sole purpose of participating in and facilitating the Arrangement by conducting the Offering (as defined below), pursuant to which, among other things, Queue proposes to acquire all of the issued and outstanding shares in the capital of Custom Health (the "Custom Shares") by way of a statutory plan of arrangement (the "Arrangement") under the Business Corporations Act (British Columbia) (the "Transaction"). Pursuant to the Arrangement Agreement, and upon the satisfaction or waiver of the conditions set out therein, the following, among other things, will be completed in connection with the consummation of the Transaction: (i) Custom Health will merge with Merger Sub pursuant to the provisions of the Delaware General Corporations Law (the "Merger"); (ii) Custom Fundco will amalgamate with Queue Subco pursuant to the provisions of the Business Corporations Act (British Columbia) (the "Amalgamation"); (iii) the company resulting from the Merger will become a wholly-owned subsidiary of Queue; (iv) the company resulting from the Amalgamation will convey its assets to Queue and be subsequently wound-up; and (v) the securityholders of Custom Health will hold substantially equivalent securities of Queue (following the Transaction, the "Resulting Issuer"). Resulting Issuer Following the completion of the Transaction ("Closing"), the Resulting Issuer will operate as a health technology and solutions company. Closing is subject to a number of conditions, which include, among others, closing of the Offering, receipt of all necessary board, shareholder and regulatory approvals, including the conditional approval of the listing of the common shares of the Resulting Issuer ("Resulting Issuer Shares") on the Toronto Stock Exchange (the "TSX") (the "Listing"). The Listing will be subject to satisfying all of the TSX's initial listing requirements as an Industrial/Technology issuer. Custom Health will also convene a meeting of its shareholders for the purposes of approving the Merger. Immediately prior to Closing, the Resulting Issuer is expected to change its name to "Custom Health Holdings Inc." or such other name as may be agreed to by the parties and accepted by applicable regulators. The Offering Stifel shall act as lead agent and sole bookrunner in connection with the Offering. Stifel has also been granted an option (the "Agents' Option") to increase the size of the Offering by up to 15% which Agents' Option shall be exercisable in whole or in part at any time for up to 48 hours prior to the closing of the Offering (the "Offering Closing Date"). Each FundCo Subscription Receipt will automatically convert into one common share in the capital of Custom FundCo (each, a "FundCo Share") upon satisfaction of certain escrow release conditions (the "Escrow Release Conditions"), subject to adjustment in certain events, at no additional cost to the holder as described in a subscription receipt agreement to be entered into by the parties and a mutually acceptable escrow agent. In connection with Closing, each FundCo Share received by holders of the FundCo Subscription Receipts shall then be converted into one Resulting Issuer Share pursuant to the Amalgamation. In the event that the Escrow Release Conditions are not satisfied prior to the date that is 180 days after the Offering Closing Date or such later date as mutually agreed, the escrow agent will return to holders of FundCo Subscription Receipts an amount equal to the aggregate issue price of the FundCo Subscription Receipts held by them and their pro rata portion of any interest earned thereon. Subject to the receipt of all requisite approvals, the Offering is expected to be completed on or about July 15, 2025 or such other date to be determined between Custom Health, Queue and Stifel. The Resulting Issuer intends to use the net proceeds from the Offering for working capital and general corporate purposes. Following completion of the Transaction, the Resulting Issuer Shares received upon conversion of the FundCo Shares will not be subject to a statutory hold period in Canada. Sponsorship Under the policies of the TSX, the parties to the Transaction will be required to engage a sponsor for the Transaction unless an exemption or waiver from this requirement can be obtained. Disclosure Document In connection with the Transaction, Queue will file a management information circular or other disclosure document under Queue's profile on SEDAR+ at which will contain details regarding the Transaction, the Arrangement, the Offering, the Debt Financing, Queue, Custom Health and the Resulting Issuer (including applicable financial statements). In the event any of the conditions set forth above are not completed or the Transaction does not proceed, Queue will notify shareholders. This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction. About Queue Ventures Ltd. Queue was formed under the Business Corporations Act (British Columbia) on October 29, 2021 and is an unlisted reporting issuer in each of British Columbia and Alberta. Queue has no commercial operations and no assets other than cash. About Custom Health Custom Health provides a comprehensive technology-enabled medication management and managed care solution, resulting in 98%1 medication adherence for its patients across the United States and Canada. Custom Health is focused on serving poly-med patients with chronic conditions, representing an estimated market of 78 million2 adults in North America. These patients take multiple medications several times throughout the day and often struggle to adhere to their prescription regimen, presenting a significant challenge and costing the North American healthcare system an estimated US$550 billion per year3. Further Information Queue and Custom Health plan to issue additional press releases providing further details in respect of the Transaction, the Offering, the Debt Financing and other material information as it becomes available. For further information, please contact Custom Health This press release does not constitute an offer of securities for sale in the United States. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States absent U.S. registration or an applicable exemption from U.S. registration requirements. As noted above, completion of the Transaction is subject to a number of conditions. There can be no assurance that the Transaction will be completed as proposed or at all. Investors are cautioned that, except as disclosed in the management information circular or other disclosure document to be prepared in connection with the Transaction, any information released or received with respect to the Transaction may not be accurate or complete and should not be relied upon. No stock exchange or regulatory authority has passed upon the merits of the Transaction or approved or disapproved of the contents of this news release. All information contained in this news release with respect to Queue was supplied by Queue, and Custom Health and its directors and officers have relied on Queue for such information. Cautionary Note Regarding Forward-Looking Information This press release contains statements which constitute "forward-looking information" within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of Queue and Custom Health with respect to the Transaction, the Offering, the Debt Financing, the Listing, and the future business activities and operating performance of the Resulting Issuer. Forward-looking information is often identified by the words "may", "would", "could", "should", "will", "intend", "plan", "anticipate", "believe", "estimate", "expect" or similar expressions and includes information regarding: expectations regarding whether the Transaction will be consummated and whether the Offering or Debt Financing will be completed, including whether conditions to the consummation of the Transaction and completion of the Offering and Debt Financing will be satisfied, the timing and terms for completing the Transaction and the Offering and Debt Financing, and expectations for the effects of the Transaction or the ability of the Resulting Issuer to successfully achieve business objectives. Investors are cautioned that forward-looking information is not based on historical facts but instead reflect management of Queue and Custom Health's management, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although Queue and Custom Health believe that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the combined company. The reader should not place undue reliance on these forward-looking statements, as there can be no assurances that the plans, initiatives or expectations upon which they are based will occur. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: the ability to consummate the Transaction and/or the Offering and Debt Financing; the ability of Custom Health to meet its obligations under its material agreements; the ability to obtain requisite regulatory and other approvals and the satisfaction of other conditions to the consummation of the Transaction and/or the Offering and Debt Financing on the proposed terms and schedule; investor demand and interest in the Offering and Debt Financing; the potential impact of the announcement or consummation of the Transaction and/or the Offering and Debt Financing on relationships, including with regulatory bodies, employees, suppliers, customers and competitors; changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation; and the diversion of management time on the Transaction and/or the Offering and Debt Financing. This forward-looking information may be affected by risks and uncertainties in the business of Queue and Custom Health and market conditions. Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward- looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although Queue and Custom Health have attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. Queue and Custom Health do not intend, and do not assume any obligation, to update this forward-looking information except as otherwise required by applicable law. ________________________ 1 BMC Geriatrics, "Medication adherence support of an in-home electronic medication dispensing system for individuals living with chronic conditions: a pilot randomized controlled trial" 2 CDC, "Prevalence of Multiple Chronic Conditions Among US Adults, 2018"; Statistics Canada; BMC, "Chronic disease multimorbidity among the Canadian population: prevalence and associated lifestyle factors"; Statista, "Resident population of Canada in 2022, by gender and age group" 3 Sage Journals, "Cost of Prescription Drug-Related Morbidity and Mortality"; National Library of Medicine, "Cost-related nonadherence to prescription medications in Canada: a scoping review" # # # Not for distribution to United States newswire services or for dissemination in the United States. To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
30-05-2025
- Business
- Yahoo
Osisko Metals Announces Voting Results of Annual and Special Meeting of Shareholders
MONTRÉAL, May 29, 2025 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the "Company" or "Osisko Metals") (TSX-V: OM; OTCQX: OMZNF; FRANKFURT: OB51) announces the results of its annual and special meeting of shareholders of the Company (the "Meeting") held earlier today. A total of 290,548,699 common shares of the Company ("Common Shares") were represented, in person or by proxy, at the Meeting, representing approximately 47.67% of the total issued and outstanding Common Shares as of the record date of the Meeting. All matters presented for shareholder approval at the Meeting were overwhelmingly approved as follows: Setting the board size at nine (over 99% in favour); Electing Robert Wares, John Burzynski, Jeff Hussey, Amy Satov, Cathy Singer, Donald Siemens, Peter Wright, Patrick F.N. Anderson, and Tara Christie as directors of the Company (over 99% in favour of each director); Appointing PricewaterhouseCoopers LLP as auditor of the Company and authorizing directors to fix their remuneration (over 99% in favour); Authorizing and approving the continuance of the Company from British Columbia to Ontario and adopting a new by-law upon such continuance (over 95% in favour); Authorizing the board of directors to set the number of directors of the Company in accordance with Section 125(3) of the Business Corporations Act (Ontario), conditional upon the effectiveness of the continuance into Ontario (over 95% in favour); Approving certain prior grants of restricted share units and deferred share units (over 99% of disinterested shareholders in favour); and Approving the Company's omnibus equity incentive plan (the "Omnibus Plan") (over 99% in favour). The Omnibus Plan was adopted by the board of directors of the Company on January 17, 2025. The Omnibus Plan is a fixed 10% plan and provides for the grant of options, restricted share units, performance share units and deferred share units. The aggregate maximum number of Common Shares reserved for issuance pursuant to the Omnibus Plan is 60,956,063 Common Shares (less any Common Shares reserved for issuance under other share compensation arrangements of the Company). The Omnibus Plan has received conditional acceptance from the TSX Venture Exchange. For more details regarding the matters presented at the Meeting, please refer to the management information circular dated April 9, 2025, which is accessible on SEDAR+ ( under the Company's issuer profile and on the Company's website at About Osisko Metals Osisko Metals Incorporated is a Canadian exploration and development company creating value in the critical metals sector, with a focus on copper and zinc. The Company acquired a 100% interest in the past-producing Gaspé Copper mine from Glencore Canada Corporation in July 2023. The Gaspé Copper mine is located near Murdochville in Québec's Gaspé Peninsula. The Company is currently focused on resource expansion of the Gaspé Copper system, with current Indicated Mineral Resources of 824 Mt grading 0.34% CuEq and Inferred Mineral Resources of 670 Mt grading 0.38% CuEq (in compliance with NI 43-101). For more information, see Osisko Metals' November 14, 2024 news release entitled "Osisko Metals Announces Significant Increase in Mineral Resource at Gaspé Copper". Gaspé Copper hosts the largest undeveloped copper resource in eastern North America, strategically located near existing infrastructure in the mining-friendly province of Québec. In addition to the Gaspé Copper project, the Company is working with Appian Capital Advisory LLP through the Pine Point Mining Limited joint venture to advance one of Canada's largest past-producing zinc mining camps, the Pine Point project, located in the Northwest Territories. The current mineral resource estimate for the Pine Point project consists of Indicated Mineral Resources of 49.5 Mt at 5.52% ZnEq and Inferred Mineral Resources of 8.3 Mt at 5.64% ZnEq (in compliance with NI 43-101). For more information, see Osisko Metals' June 25, 2024 news release entitled "Osisko Metals releases Pine Point mineral resource estimate: 49.5 million tonnes of indicated resources at 5.52% ZnEq". The Pine Point project is located on the south shore of Great Slave Lake, Northwest Territories, close to infrastructure, with paved road access, an electrical substation and 100 kilometers of viable haul roads. For further information on this news release, visit or contact: Robert Wares, Chief Executive Officer of Osisko Metals IncorporatedEmail: info@ (514) 861-4441 Cautionary Statement on Forward-Looking Information This news release contains "forward-looking information" within the meaning of applicable Canadian securities legislation based on expectations, estimates and projections as at the date of this news release. Any statement that involves predictions, expectations, interpretations, beliefs, plans projections, objectives, assumptions, future events or performance (often, but not always, using phrases such as "expects", or "does not expect", "is expected", "interpreted", "management's view", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "potential", "feasibility", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken, occur or be achieved) are not statements of historical fact and may be forward-looking information and are intended to identify forward-looking information. This news release contains forward-looking information pertaining to, among other things: the anticipated resource expansion of the Gaspé Copper system; Gaspé Copper hosting the largest undeveloped copper resource in eastern North America; and the advancement of the Pine Point project. Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management, in light of management's experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances. Forward-looking information involves risks, uncertainties and other factors that could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Factors that could cause actual results to differ materially from such forward-looking information are set out in the Company's public disclosure record on SEDAR+ ( under Osisko Metals' issuer profile. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward- looking information, whether as a result of new information, future events or otherwise, other than as required by law. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
29-05-2025
- Business
- Yahoo
Osisko Metals Announces Voting Results of Annual and Special Meeting of Shareholders
MONTRÉAL, May 29, 2025 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the "Company" or "Osisko Metals") (TSX-V: OM; OTCQX: OMZNF; FRANKFURT: OB51) announces the results of its annual and special meeting of shareholders of the Company (the "Meeting") held earlier today. A total of 290,548,699 common shares of the Company ("Common Shares") were represented, in person or by proxy, at the Meeting, representing approximately 47.67% of the total issued and outstanding Common Shares as of the record date of the Meeting. All matters presented for shareholder approval at the Meeting were overwhelmingly approved as follows: Setting the board size at nine (over 99% in favour); Electing Robert Wares, John Burzynski, Jeff Hussey, Amy Satov, Cathy Singer, Donald Siemens, Peter Wright, Patrick F.N. Anderson, and Tara Christie as directors of the Company (over 99% in favour of each director); Appointing PricewaterhouseCoopers LLP as auditor of the Company and authorizing directors to fix their remuneration (over 99% in favour); Authorizing and approving the continuance of the Company from British Columbia to Ontario and adopting a new by-law upon such continuance (over 95% in favour); Authorizing the board of directors to set the number of directors of the Company in accordance with Section 125(3) of the Business Corporations Act (Ontario), conditional upon the effectiveness of the continuance into Ontario (over 95% in favour); Approving certain prior grants of restricted share units and deferred share units (over 99% of disinterested shareholders in favour); and Approving the Company's omnibus equity incentive plan (the "Omnibus Plan") (over 99% in favour). The Omnibus Plan was adopted by the board of directors of the Company on January 17, 2025. The Omnibus Plan is a fixed 10% plan and provides for the grant of options, restricted share units, performance share units and deferred share units. The aggregate maximum number of Common Shares reserved for issuance pursuant to the Omnibus Plan is 60,956,063 Common Shares (less any Common Shares reserved for issuance under other share compensation arrangements of the Company). The Omnibus Plan has received conditional acceptance from the TSX Venture Exchange. For more details regarding the matters presented at the Meeting, please refer to the management information circular dated April 9, 2025, which is accessible on SEDAR+ ( under the Company's issuer profile and on the Company's website at About Osisko Metals Osisko Metals Incorporated is a Canadian exploration and development company creating value in the critical metals sector, with a focus on copper and zinc. The Company acquired a 100% interest in the past-producing Gaspé Copper mine from Glencore Canada Corporation in July 2023. The Gaspé Copper mine is located near Murdochville in Québec's Gaspé Peninsula. The Company is currently focused on resource expansion of the Gaspé Copper system, with current Indicated Mineral Resources of 824 Mt grading 0.34% CuEq and Inferred Mineral Resources of 670 Mt grading 0.38% CuEq (in compliance with NI 43-101). For more information, see Osisko Metals' November 14, 2024 news release entitled "Osisko Metals Announces Significant Increase in Mineral Resource at Gaspé Copper". Gaspé Copper hosts the largest undeveloped copper resource in eastern North America, strategically located near existing infrastructure in the mining-friendly province of Québec. In addition to the Gaspé Copper project, the Company is working with Appian Capital Advisory LLP through the Pine Point Mining Limited joint venture to advance one of Canada's largest past-producing zinc mining camps, the Pine Point project, located in the Northwest Territories. The current mineral resource estimate for the Pine Point project consists of Indicated Mineral Resources of 49.5 Mt at 5.52% ZnEq and Inferred Mineral Resources of 8.3 Mt at 5.64% ZnEq (in compliance with NI 43-101). For more information, see Osisko Metals' June 25, 2024 news release entitled "Osisko Metals releases Pine Point mineral resource estimate: 49.5 million tonnes of indicated resources at 5.52% ZnEq". The Pine Point project is located on the south shore of Great Slave Lake, Northwest Territories, close to infrastructure, with paved road access, an electrical substation and 100 kilometers of viable haul roads. For further information on this news release, visit or contact: Robert Wares, Chief Executive Officer of Osisko Metals IncorporatedEmail: info@ (514) 861-4441 Cautionary Statement on Forward-Looking Information This news release contains "forward-looking information" within the meaning of applicable Canadian securities legislation based on expectations, estimates and projections as at the date of this news release. Any statement that involves predictions, expectations, interpretations, beliefs, plans projections, objectives, assumptions, future events or performance (often, but not always, using phrases such as "expects", or "does not expect", "is expected", "interpreted", "management's view", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "potential", "feasibility", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken, occur or be achieved) are not statements of historical fact and may be forward-looking information and are intended to identify forward-looking information. This news release contains forward-looking information pertaining to, among other things: the anticipated resource expansion of the Gaspé Copper system; Gaspé Copper hosting the largest undeveloped copper resource in eastern North America; and the advancement of the Pine Point project. Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management, in light of management's experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances. Forward-looking information involves risks, uncertainties and other factors that could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Factors that could cause actual results to differ materially from such forward-looking information are set out in the Company's public disclosure record on SEDAR+ ( under Osisko Metals' issuer profile. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward- looking information, whether as a result of new information, future events or otherwise, other than as required by law. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
